Papers - ZHAO Songji
-
Comparative evaluation of 18F-DiFA and its analogues as novel hypoxia positron emission tomography and 18F-FMISO as the standard
Nakata N, Kiriu M, Okumura Y, Zhao S, Nishijima K, Shiga T, Tamaki N, Kuge Y, Matsumoto H
Nucl Med Biol 70 39 - 45 2019.3
-
A novel PET probe [18F]DiFA accumulates in hypoxic region via glutathione conjugation following reductive metabolism
Shimizu Y, Zhao S, Yasui H, Nishijima K, Matsumoto H, Siga T, Tamaki N, Ogawa M, Kuge Y
Mol Imaging Biol 21 ( 1 ) 122 - 129 2019.2
-
[18F]DPA-714 PET imaging shows immunomodulatory effect of intravenous administration of bone marrow stromal cells after transient focal ischemia.
Tan C, Zhao S, Higashikawa K, Wang Z, Kawabori M, Abumiya T, Nakayama N, Kazumata K, Ukon N, Yasui H, Tamaki N, Kuge Y, Shichinohe H, Houkin K
EJNMMI Res 8 ( 1 ) 35 2018.5
-
In vitro uptake and metabolism of [14C]Acetate in rabbit atherosclerotic arteries: Biological basis for atherosclerosis imaging with [11C]Acetate.
Yamasaki K, Yamashita A, Zhao Y, Shimizu Y, Nishii R, Kawai K, Tamaki N, Zhao S, Asada Y, Kuge Y
Nucl Med Biol 56 ( 8 ) 21 - 25 2018.1
-
<sup>111</sup>In-DTPA-d-Phe<sup>-1</sup>-Asp<sup>0</sup>-d-Phe<sup>1</sup>-octreotide exhibits higher tumor accumulation and lower renal radioactivity than <sup>111</sup>In-DTPA-d-Phe<sup>1</sup>-octreotide.
Oshima N, Akizawa H, Kitaura H, Kawashima H, Zhao S, Zhao Y, Nishijima KI, Kitamura Y, Arano Y, Kuge Y, Ohkura K
Nuclear medicine and biology 54 18 - 26 2017.11（ ISSN:0969-8051 ）
-
FMISO accumulation in tumor is dependent on glutathione conjugation capacity in addition to hypoxic state.
Masaki Y, Shimizu Y, Yoshioka T, Nishijima KI, Zhao S, Higashino K, Numata Y, Tamaki N, Kuge Y
Annals of nuclear medicine 31 ( 8 ) 596 - 604 2017.10（ ISSN:0914-7187 ）
-
Nesfatin-1 inhibits voltage gated K<sup>+</sup> channels in pancreatic beta cells.
Maejima Y, Horita S, Kobayashi D, Aoki M, O'hashi R, Imai R, Sakamoto K, Mori M, Takasu K, Ogawa K, Takenoshita S, Zhao S, Hazama A, Shimomura K
Peptides 95 10 - 15 2017.9（ ISSN:0196-9781 ）
-
Changes in tumor oxygen states after sorafenib therapy evaluated by 18F-fluoromisonidazole hypoxia imaging in a renal cell cancer xenograft
Yu W, Zhao S, Zhao Y, Fatema CN, Murakami M, Nishijima K, Kitagawa Y, Tamaki N, Kuge Y
Oncology Letters in press 2017.6
-
Altered glucose metabolism and hypoxic response in alloxan-induced diabetic atherosclerosis in rabbits
Matsuura Y, Yamashita A, Zhao Y, Iwakiri T, Yamasaki K, Sugita C , Koshimoto C, Kitamura K, Kawai K, Tamaki N, Zhao S, Kuge Y, Asada Y
PLoS One 12 ( 4 ) e0175976 2017.4
-
Redesign of negatively charged 111In-DTPA-octreotide derivative to reduce renal radioactivity. Nucl Med and Biol
Oshima N, Akizawa H, Kawashima H, Zhao S, Zhao Y, Nishijima K, Kitamura Y, Arano Y, Kuge Y, Ohkura K
Nucl Med Biol 48 ( 1 ) 16 - 25 2017.1
-
Optimization of Helical Acquisition Parameters to Preserve Uniformity of Mouse Whole Body using Multipinhole Collimator in Single-Photon Emission Computed Tomography
Ukon N, Kubo N, Ishikawa M, Zhao S, Tamaki N, Kuge Y
Results in Physics 2017
-
Immunoglobulin-G (IgG)-based imaging probe accumulates in M1 macrophage-infiltrated atherosclerotic plaques independent of IgG target molecule expression
Shimizu Y, Hanzawa H, Zhao Y, Fukura S, Nishijima K, Sakamoto T, Zhao S, Tamaki N, Ogawa M, Kuge Y
Mol Imaging Biol 2016.12
-
Dynamic PET evaluation of the elevated FLT uptake level after sorafenib treatment in mice bearing a human renal cell carcinoma xenograft
Ukon N, Zhao S, Yu W, Shimizu Y, Nishijima K, Kubo N, Kitagawa Y, Tamaki N, Higashikawa K, Yasui H, and Kuge Y
EJNMMI Research 6 ( 1 ) 90 2016.12
-
INVITED PERSPECTIVE FOR: Advanced Molecular Imaging for Exploring Classical Conditioning and Extinction
Zhao S, Fatema CN, Zhao JM, and Nan GX
J Nucl Med 57 ( 9 ) 1333 2016.9
-
The Thymidine Phosphorylase Imaging Agent 123I-IIMU Predicts the Efficacy of Capecitabine.
Kobashi N, Matsumoto H, Zhao S, Meike S, Okumura Y, Abe T, Akizawa H, Ohkura K, Ken-Ichi N, Tamaki N, Kuge Y
Journal of nuclear medicine 57 ( 8 ) 1276 - 1281 2016.8
-
Characterization of the role of sphingomyelin synthase 2 in glucose metabolism in whole-body and peripheral tissues in mice
Sugimoto M, Shimizu Y, Zhao S, Ukon N, Nishijima K, Wakabayashi M, Yoshioka T, Higashino K, Numata Y, Okuda T, Tamaki N, Hanamatsu H, Igarashi Y, Kuge Y
Biochimica et biophysica acta 1861 ( 8 Pt A ) 688 - 702 2016.8
-
Imaging Mass Spectrometry Reveals Acyl-Chain- and Region-Specific Sphingolipid Metabolism in the Kidneys of Sphingomyelin Synthase 2-Deficient Mice.
Sugimoto M, Wakabayashi M, Shimizu Y, Yoshioka T, Higashino K, Numata Y, Okuda T, Zhao S, Sakai S, Igarashi Y, Kuge Y
PloS one 11 ( 3 ) e0152191 2016.5
-
The accumulation mechanism of the hypoxia imaging probe "FMISO"" by imaging mass spectrometry: possible involvement of low-molecular metabolites.
Masaki Y, Shimizu Y, Yoshioka T, Tanaka Y, Nishijima KI, Zhao S, Higashino K, Sakamoto S, Numata Y, Yamaguchi Y, Tamaki N, Kuge Y
Scientific reports 5 16802 2015.11
-
Combined Plasma and Tissue Proteomic Study of Atherogenic Model Mouse: Approach To Elucidate Molecular Determinants in Atherosclerosis Development.
Hanzawa H, Sakamoto T, Kaneko A, Manri N, Zhao Y, Zhao S, Tamaki N, Kuge Y
Journal of proteome research 14 ( 10 ) 4257 - 4269 2015.10
-
Biodistribution and dosimetry of free 211At and meta-[211At]astatobenzylguanidine (211At-MABG) in normal mice
10. Ukon N, Zhao S, Washiyama K, Oriuchi N, Tan C, Shimoyama S, Aoki M, Kubo H, Takahashi K, Itoh H
EJNMMI Physics 7 ( 1 ) 58 2020.9